Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating ABT-494 (Upadacitinib) in adults with moderate to severe atopic dermatitis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Vitamin D in Egyptian Children With Atopic Dermatitis [Phase 3]
Phase 3 trial update on vitamin D in Egyptian children with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating two regimens of Crisaborole 2% ointment in Japanese participants aged 2+, assessing efficacy and safety for mild to…
-
FDA approval · 2020-07-14FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Viona Pharmaceuticals Inc)
FDA approved the original application for Betamethasone Dipropionate by Viona Pharmaceuticals Inc, granting it as a generic topical corticos…
-
FDA approval · 2020-07-07FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The U.S. FDA approved a supplemental application for betamethasone dipropionate from Glenmark Pharmaceuticals Inc., USA. This action adds re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment [Phase 3]
Phase 3 trial comparing clemastine fumarate with dexamethasone to dexchlorpheniramine in eczema; study completed.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Study of OPA-15406 Ointment in Patients With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial of OPA-15406 ointment in atopic dermatitis completed with results posted.
-
FDA approval · 2020-06-17FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original application for Betamethasone Dipropionate topical, a potent corticosteroid for inflammatory …
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Validation of the Short-term Antimicrobial Action of Transplanted Bacteria [Phase 1]
Phase 1 trial assessing short-term antimicrobial action of transplanted bacteria for atopic dermatitis has completed with results posted.
-
FDA approval · 2020-06-15FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., indicating an approval related to the gene…
-
FDA approval · 2020-06-09FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Betamethasone Dipropionate by Actavis Pharma, Inc., indicating an update to the product's approv…
-
FDA approval · 2020-06-01FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's Triamcinolone acetonide via an Original Application (ANDA) for a generic formulation.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Targeted Microbiome Transplant in Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a targeted microbiome transplant for atopic dermatitis has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 trial update evaluating GBR 830 versus placebo in adults with moderate-to-severe atopic dermatitis; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) [Phase 2]
Phase 2 clinical trial update evaluating dupilumab and immune responses in adults with atopic dermatitis. Results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis [Phase 3]
Phase 3 trial assessing equivalence of generic pimecrolimus cream 1% to Elidel 1% in mild to moderate atopic dermatitis completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients [Phase 2]
Phase 2 safety and efficacy study of Q301 in adolescents and adults with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating PF-04965842 in adolescents and adults with moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Mast Cell Activation Test in Allergic Disease
Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Topical NanoDox® for Atopic Dermatitis [Phase 2]
Phase 2 trial update for Topical NanoDox® in atopic dermatitis completed with posted results.
-
FDA approval · 2020-03-23FDA Approved: EUCRISA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for EUCRISA (crisaborole) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD) [Phase 2]
Phase 2 trial assessing safety and effectiveness of dupilumab for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 bioequivalence study comparing pimecrolimus 1% cream to Elidel 1% cream in mild to moderate atopic dermatitis has completed with r…
-
FDA approval · 2020-03-04FDA Approved: HYDROCORTISONE VALERATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved the original application for hydrocortisone valerate by Cosette Pharmaceuticals, Inc., establishing a new generic topical corti…
-
FDA approval · 2020-02-10FDA Approved: FLUOCINONIDE — Original Application (Zydus Lifesciences Limited)
The FDA approved the original application for a generic fluocinolone topical product from Zydus Lifesciences Limited. The approval confirms …